Skip to main content
SpringerLink
Log in

Low-grade urinary albumin excretion in normotensive/non-diabetic obstructive sleep apnea patients

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Previous studies have indicated that high levels of urinary albumin excretion (UAE) are associated with an increased incidence of cardiovascular morbidity and mortality. This study examined the association between UAE and obstructive sleep apnea syndrome (OSAS). The study included 35 newly diagnosed OSAS patients and 11 nonapneic controls. Subjects with diabetes mellitus, hypertension, a history of renal failure, cardiac failure, coronary heart disease, collagen tissue disease, high serum creatinine, and urinary infection, and who use angiotensin-converting enzyme inhibitors and were women were excluded from the study. A single void morning urine sample at the baseline examination was used to measure UAE. There were no significant differences in the age, body mass index (BMI), and smoking habits of the OSAS patients and controls. UAE of the OSAS group was significantly higher than that of the control group (23.3 ± 6.1 μg/min vs. 6.5 ± 2.1 μg/min, respectively; P = 0.002). UAE was positively correlated to length of time spent at an oxygen saturation of <90% (r = 0.503, P = 0.002) and BMI (r = 0.361, P = 0.033). Regression analyses (r 2 = 0.504, P < 0.0001) showed that the length of time spent at an oxygen saturation of <90% (P < 0.0001) was risk factor for UAE, independent of age and BMI. Our study supports the notion that low-grade UAE is associated with non-hypertensive/non-diabetic OSAS, independent of age and BMI. Low-grade UAE may be a marker for subclinical vascular damage that predisposes OSAS patients to future cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. ASDA-Diagnostic Classification Steering Committee (1997) The international classification of sleep disorders. Diagnostic and coding manual, 2nd edn. Allen, Lawrence, KS

    Google Scholar 

  2. Roux F, D’Ambrosio C, Mohsenin V (2000) Sleep-related breathing disorders and cardiovascular disease. Am J Med 108:396–402

    Article  PubMed  CAS  Google Scholar 

  3. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053

    PubMed  Google Scholar 

  4. Bixler EO, Vgontzas AN, Lin H-M et al (2001) Prevalence of sleep disorders breathing in women; effects of gender. Am J Respir Crit Care Med 163:608–613

    PubMed  CAS  Google Scholar 

  5. Peker Y, Hedner J, Norum J et al (2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166:159–165

    Article  PubMed  Google Scholar 

  6. Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in large community based study. JAMA 283:1829–1836

    Article  PubMed  CAS  Google Scholar 

  7. Mooe T, Rabben T, Wiklund U et al (1996) Sleep-disordered breathing in men with coronary artery disease. Chest 109:659–663

    Article  PubMed  CAS  Google Scholar 

  8. Arias MA, Garcia-RIO F, Alonso-Fernandez A et al (2006) Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 27:1106–1113

    Article  PubMed  Google Scholar 

  9. American Diabetes Association (2001) Clinical recommendations 2001: diabetic nephropathy. Diabetes Care 24(suppl 1):S69–S72

    Google Scholar 

  10. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension and diabetes. Circulation 110:32–35

    Article  PubMed  CAS  Google Scholar 

  11. Bigazzi R, Bianchi S, Baldari D, Campese VM (1998) Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 16:1325–1333

    Article  PubMed  CAS  Google Scholar 

  12. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K (2000) Arterial hypertension, microalbuminuria and risk of ischemic heart disease. Hypertension 35:898–903

    PubMed  CAS  Google Scholar 

  13. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage: the steno hypothesis. Diabetologia 32:219–226

    Article  PubMed  CAS  Google Scholar 

  14. Agewall S, Bjorn F (2002) Microalbuminuria and intima–media thickness of the carotid artery in clinically healthy men. Atherosclerosis 164:161–166

    Article  PubMed  CAS  Google Scholar 

  15. Chaudhary BA, Rehman OU, Brown TM (1995) Proteinuria in patients with sleep apnea. J Fam Pract 40:139–141

    PubMed  CAS  Google Scholar 

  16. Iliescu EA, Lam M, Pater J et al (2001) Do patients with obstructive sleep apnea have clinically significant proteinuria. Clin Nephrol 55:196–204

    PubMed  CAS  Google Scholar 

  17. Casserly LF, Chow N, Ali S et al (2001) Proteinuria in obstructive sleep apnea. Kidney Int 60:1484–1489

    Article  PubMed  CAS  Google Scholar 

  18. Rechtschaffen A, Kales A (1973) (Eds). A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. 3. Edition. Los Angeles: Brain Research Institute, 1–13

  19. Bonnet M, Charley D, Carskadon MA (1992) EEG arousals scoring rules and examples. Sleep 15:174–184

    Google Scholar 

  20. Dincer HE, O’Neill W (2006) Deleterious effect of sleep breathing disorders on the heart and vascular system. Respiration 73:124–130

    Article  PubMed  Google Scholar 

  21. Gerstein HC, Mann JF, Yi Q et al (2001) Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426

    Article  PubMed  CAS  Google Scholar 

  22. Zenere BM, Arcaro G, Saggiani F, Rossi L, Muggeo M, Lechi A (1995) Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care 18:975–982

    Article  PubMed  CAS  Google Scholar 

  23. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B (2001) Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 103:1869–1874

    PubMed  CAS  Google Scholar 

  24. Wang TJ, Evans JC, Meigs JB et al (2005) Low-grade albuminuria and the risk of hypertension and blood pressure progression. Circulation 111:1370–1376

    Article  PubMed  CAS  Google Scholar 

  25. Hillege HL, Fidler V, Diercks GFH et al (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777–1782

    Article  PubMed  CAS  Google Scholar 

  26. Ibsen H, Wachtell K, Olsen MH et al (2004) Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy. J Hypertens 22:1805–1811

    Article  PubMed  CAS  Google Scholar 

  27. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M (2001) The Copenhagen City Heart Study. Eur Heart J 3(Suppl):H1–83

    Google Scholar 

  28. Ärnlöv J, Evans JC, Meigs Jb et al (2005) Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals. The Framingham Heart Study. Circulation 112:969–975

    Article  PubMed  Google Scholar 

  29. Kramer H, Jacobs DR, Bild DJ et al (2005) Urine albumin excretion and subclinical cardiovascular disease. The multi-ethnic study of atherosclerosis. Hypertension 46:38–43

    Article  PubMed  CAS  Google Scholar 

  30. Lieb W, Mayer B, Stritzke J et al (2006) Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population. The MONICA/KORA Augsburg echocardiographic substudy. Nephrol Dial Transplant 21:2780–1787

    Article  PubMed  CAS  Google Scholar 

  31. Mello P, Franger M, Boujaoude Zi et al (2004) Night and day proteinuria in patients with sleep apnea. Am J Kidney Dis 44:636–641

    Article  PubMed  Google Scholar 

  32. Kvenild K, Romundstad S, Midthjell K et al (2006) Microalbuminuria in treated hypertensives: only a mirror image of cardiovascular risk. Scand J Prim Health Care 24:145–153

    Article  PubMed  Google Scholar 

  33. Jensen JS (1995) Intra-individual variation of overnight urinary albumin excretion in clinically healthy middle-aged individuals. Clin Chim Acta 243:95–99

    Article  PubMed  CAS  Google Scholar 

  34. Eknoyan G, Hostetter T, Bakris GL et al (2003) Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 42:616–622

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pulmonary Medicine, School of Medicine, University of Uludağ, Bursa, Turkey

    Ahmet Ursavas, Mehmet Karadag, Ezgi Demirdogen, Funda Coskun & R. Oktay Gozu

  2. Department of Nephrology, School of Medicine, University of Uludağ, Bursa, Turkey

    Mustafa Gullulu

  3. Department of Otolaryngology–Head and Neck Surgery, School of Medicine, University of Uludağ, Bursa, Turkey

    Selcuk Onart

  4. Uludağ Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları ve Tüberküloz AD, 16059 Görükle, Bursa, Turkey

    Ahmet Ursavas

Authors
  1. Ahmet Ursavas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Karadag
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mustafa Gullulu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ezgi Demirdogen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Funda Coskun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Selcuk Onart
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Oktay Gozu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmet Ursavas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ursavas, A., Karadag, M., Gullulu, M. et al. Low-grade urinary albumin excretion in normotensive/non-diabetic obstructive sleep apnea patients. Sleep Breath 12, 217–222 (2008). https://doi.org/10.1007/s11325-008-0169-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-008-0169-7

Keywords

Search

Navigation